Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Aadi Bioscience, Inc logo — Aadi is a commercial-stage biopharmaceutical company focused...

Aadi Bioscience, Inc

Aadi is a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers.

Founded 2011 United States Los Angeles, United States 69 employees Post Ipo Equity Total: $250.50M Biopharma, Biotechnology +1

General Information

Company Name Aadi Bioscience, Inc
Founded Year 2011
Location United States Los Angeles, United States +1
Employees 69
Industries Biopharma, Biotechnology, Life Sciences
Funding Stage Post Ipo Equity
Social

Get notified when Aadi Bioscience, Inc moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Aadi Bioscience, Inc

Aadi Bioscience, Inc. is a commercial-stage biopharmaceutical company with a focus on precision therapies for genetically-defined cancers. The company leverages precision medicine and nanoparticle technology to maximize the potential of mTOR inhibition, aiming to offer transformative therapies to cancer patients with mTOR pathway driver alterations. Their lead product has received FDA approval for the treatment of adult patients with locally advanced unresectable or metastatic malignant perivascular epithelioid cell tumors (PEComa). Aadi's leadership team consists of industry veterans from top biotech companies with a track record of bringing novel cancer therapies to market. The company's science-first mindset and patient-centric approach align with its commitment to developing products for cancers with mTOR pathway driver alterations. Founded in 2011, Aadi Bioscience is headquartered in the United States. The company recently received a $72.50M Post-IPO Equity investment on 22 September 2022 from notable investors including Acuta Capital, Avoro Capital, KVP Capital, Alerce Medical Technology Partners, and Acorn Capital Advisors. For more information, please visit Aadi Bioscience.

Taxonomy: biopharmaceutical, precision therapy, mTOR inhibition, genetically-defined cancers, nanoparticle technology, FDA-approved drug, PEComa, cancer therapy, leadership team, precision medicine, patient-centric approach, mTOR pathway, oncology, clinical development, precision oncology

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 5
Investor Investor
•••• •••• 		22 Sep 2022
Post-IPO Equity •••••• 5
Investor Investor Investor Investor
•••• •••• 		26 Aug 2021
Series A •••••• - 08 May 2017

Aadi Bioscience, Inc Alternatives & Competitors

Aadi Bioscience, Inc vs
Immuneering Corporation
Immuneering Corporation United States

Helping Cancer Patients Live Longer and Feel Better

Post Ipo Equity
58 employees
Biotechnology, Pharmaceutical
Compare Aadi Bioscience, Inc vs Immuneering Corporation
Aadi Bioscience, Inc vs
NeoPhore Ltd
NeoPhore Ltd United Kingdom

Discovering drugs that create neoantigens

Series B
18 employees
Biotechnology, Health and Wellness
Compare Aadi Bioscience, Inc vs NeoPhore Ltd
Aadi Bioscience, Inc vs
Alliance for Cancer Gene Therapy
Alliance for Cancer Gene Therapy United States

Momentous change has happened, and a cancer-free future is possible -- thanks to cell and gene thera...

10 employees
Health Care, Health and Wellness
Compare Aadi Bioscience, Inc vs Alliance for Cancer Gene Therapy

FAQ About Aadi Bioscience, Inc

Aadi is a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers.
Aadi Bioscience, Inc was founded in 2011.
Aadi Bioscience, Inc is headquartered in Los Angeles, United States.
Aadi Bioscience, Inc operates in the following industries: Biopharma, Biotechnology, Life Sciences.
Aadi Bioscience, Inc has approximately 69 employees.
Aadi Bioscience, Inc has completed 3 funding rounds, raising a total of $250.50M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Aadi Bioscience, Inc include Immuneering Corporation, NeoPhore Ltd, Alliance for Cancer Gene Therapy, GenesisCare, iOnctura. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Aadi Bioscience, Inc and Immuneering Corporation are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Aadi Bioscience, Inc and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy